Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
CIA - Collegium Internationionale Allergologicum
Collegium Internationale Allergologicum
 

Session 1 - COVID, Viruses and Allergy
February 22, 2022
7:30-10:30 am CST 

Intro & Welcome
Bruce Bochner, MD


7:30-8:10 am
Keynote: Harnessing the innate immune response in the treatment of COVID-19
Professor Sir Stephen T Holgate CBE, FMedSci


8:10-8:25 am
Human surfactant protein D binds spike protein and acts as an entry inhibitor of SARS-CoV-2 pseudotyped viral particles
Miao-Hsi Hsieh
Abstract #7


8:26-8:41
Risk factors for severe COVID-19 disease in asthmatic patients
Harold Renz, MD
Abstract #26


8:42-8:57 am
SARS-CoV-2 infection in pregnancy alters maternal and cord blood immune phenotype at delivery
Jesica A. Breznik, PhD
Abstract #57


8:58-9:08 am
BREAK


9:09-9:24 am
IL-5 enhances human mast cell interferon responses to viral infection
Jean S. Marshall, PhD
Abstract #48


9:25-9:40 am
COVID-19 patients display dysregulated expression of CD48 activating and CD300a inhibitory receptors: a hint to its etiopathogenesis?
Francesca Levi-Schaffer, PhD
Abstract #41


9:41-9:56 am
Cutaneous and systemic hyperinflammation: a potential driver of maculopapular drug exanthema in severely ill COVID-19 patients
Marie-Charlotte Brüggen
Abstract #23


9:57-10:12 am
Variability of responsiveness to the BNT162b2 mRNA COVID-19 vaccine received during wildfire smoke exposure is associated with altered Natural Killer (NK) cell phenotype changes 
Gursharan Kaur Sanghar, BS
Abstract #50


10:13-10:15 am
Closing Remarks
Bruce Bochner, MD




© 2022 Collegium Internationale Allergologicum. All rights reserved.
Privacy Notice | Website Terms of Use